← Eichor
Study identifier: NCT07102628 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

Condition: Acute Coronary Syndrome  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 3
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this trial is to learn about the effects of inclisiran in people with serious heart conditions (acute coronary syndromes), when this treatment is started early after hospital admission. To do this, researchers will test the effects of inclisiran compared to placebo, when given with standard treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  +41613241111  ·  novartis.email@novartis.com

Novartis Pharmaceuticals  ·  +81337978748

Always discuss trial participation with your own doctor first.

Locations (63)

Novartis Investigative SiteClayton, Victoria, AustraliaRecruiting
Novartis Investigative SiteMontreal, Quebec, CanadaRecruiting
Novartis Investigative SiteQuébec, Quebec, CanadaRecruiting
Novartis Investigative SiteBeijing, China, ChinaRecruiting
Novartis Investigative SiteGuangzhou, Guangdong, ChinaRecruiting
Novartis Investigative SiteLuoyang, Henan, ChinaRecruiting
Novartis Investigative SiteXuzhou, Jiangsu, ChinaRecruiting
Novartis Investigative SiteNanchang, Jiangxi, ChinaRecruiting
Novartis Investigative SiteWenzhou, Zhejiang, ChinaRecruiting
Novartis Investigative SiteBeijing, ChinaRecruiting
Novartis Investigative SiteBeijing, ChinaRecruiting
Novartis Investigative SiteFuzhou, ChinaRecruiting

+ 51 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07102628